Daniel Manzur-Sandoval

Daniel Manzur-Sandoval

Auto-generated profile, based on publicly available information

Daniel Manzur-Sandoval

Cardiovascular Critical Care Unit Instituto Nacional de Cardiología Ignacio Chávez Mexico City Mexico

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
RRRoberto Rodriguez-Moncayo
Roberto Rodriguez-Moncayo
DCDiana F. Cedillo-Alcantar
Diana F. Cedillo-Alcantar
PGPablo E. Guevara-Pantoja
Pablo E. Guevara-Pantoja
OCOriana G. Chavez-Pineda
Oriana G. Chavez-Pineda
JHJose A. Hernandez-Ortiz
Jose A. Hernandez-Ortiz
JGJose L. Garcia-Cordero
Jose L. Garcia-Cordero
A microfluidic device to quantitate antibody reactivities to SARS-CoV-2 antigens: spike protein, RDB, S1 subunit, and nucleocapsid, from 50 serum samples.

29 August 2020 in Echocardiography
Verified
Journal Article
Open access
PDF file
EGEdgar García‐Cruz
Edgar García‐Cruz
DMDaniel Manzur‐Sandoval
Daniel Manzur‐Sandoval
RRRafael Rascón‐Sabido
Rafael Rascón‐Sabido
RGRodrigo Gopar‐Nieto
Rodrigo Gopar‐Nieto
RBRicardo Leopoldo Barajas‐Campos
Ricardo Leopoldo Barajas‐Campos
FBFrancisco Baranda‐Tovar
Francisco Baranda‐Tovar
Background: Coronavirus disease 2019 (COVID‐19) is characterized by severe lung involvement and hemodynamic alterations. Critical care ultrasonography is vital because it provides real time information for diagnosis and treatment. Suggested protocols for image acquisition and measurements have not yet been evaluated.Methods: This cross‐sectional study was conducted at two centers from 1 April 2020 to 30 May 2020 in adult patients with confirmed COVID‐19 infection admitted to the critical care unit. Cardiac and pulmonary evaluations were performed using the ORACLE protocol, specifically designed for this study, to ensure a structured process of image acquisition and limit staff exposure to the infection.Results: Eighty‐two consecutively admitted patients were evaluated. Most of the patients were males, with a median age of 56 years, and the most frequent comorbidities were hypertension and type 2 diabetes, and 25% of the patients had severe acute respiratory distress syndrome. The most frequent ultrasonographic findings were elevated pulmonary artery systolic pressure (69.5%), E/e’ ratio > 14 (29.3%), and right ventricular dilatation (28%) and dysfunction (26.8%). A high rate of fluid responsiveness (82.9%) was observed. The median score (19 points) on pulmonary ultrasound did not reveal any variation between the groups. Elevated pulmonary artery systolic pressure was associated with higher in‐hospital mortality.Conclusion: The ORACLE protocol was a feasible, rapid, and safe bedside tool for hemodynamic and respiratory evaluation of patients with COVID‐19. Further studies should be performed on the alteration in pulmonary hemodynamics and right ventricular function and its relationship with outcomes.

7 December 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Isis Guadalupe Montalvo OcotoxtleIsis Guadalupe Montalvo Ocotoxtle
Isis Guadalupe Montalvo Ocotoxtle
GRGustavo Rojas-Velasco
Gustavo Rojas-Velasco
OROlivia Rodríguez-Morales
Olivia Rodríguez-Morales
MAMinerva Arce-Fonseca
Minerva Arce-Fonseca
LBLuis A. Baeza-Herrera
Luis A. Baeza-Herrera
Erika Palacios-RosasErika Palacios-Rosas
Erika Palacios-Rosas
Chagas cardiomyopathy (CC), caused by the protozoan Trypanosoma cruzi, is an important cause of cardiovascular morbidity and mortality in developing countries. It is estimated that 6 to 7 million people worldwide are infected, and it is predicted that it will be responsible for 200,000 deaths by 2025. The World Health Organization (WHO) considers Chagas disease (CD) as a Neglected Tropical Disease (NTD), which must be acknowledged and detected in time, as it remains a clinical and diagnostic challenge in both endemic and non-endemic regions and at different levels of care. The literature on CC was analyzed by searching different databases (Medline, Cochrane Central, EMBASE, PubMed, Google Scholar, EBSCO) from 1968 until October 2022. Multicenter and bioinformatics trials, systematic and bibliographic reviews, international guidelines, and clinical cases were included. The reference lists of the included papers were checked. No linguistic restrictions or study designs were applied. This review is intended to address the current incidence and prevalence of CD and to identify the main pathogenic mechanisms, clinical presentation, and diagnosis of CC.

30 November 2021 in Global Heart
Verified
Journal Article
Open access
PDF file
HGHéctor Gonzalez-Pacheco
Héctor Gonzalez-Pacheco
DMDaniel Manzur-Sandoval
Daniel Manzur-Sandoval
RGRodrigo Gopar-Nieto
Rodrigo Gopar-Nieto
AÁAmada Álvarez-Sangabriel
Amada Álvarez-Sangabriel
CMCarlos Martínez-Sánchez
Carlos Martínez-Sánchez
AAAlexandra Arias-Mendoza
Alexandra Arias-Mendoza
Latin America has limited information about the full spectrum cardiogenic shock (CS) and its hospital outcome. This study sought to examine the temporal trends, clinical features and outcomes of patients with CS in a coronary care unit of single Mexican institution. This was a retrospective study of consecutive patients hospitalized with CS in a Mexican teaching hospital between 2006–2019. Patients were classified according to the presence or absence of acute myocardial infarction (AMI). Of 22,747 admissions, 833 (3.7%) exhibited CS. Among patients with AMI (n = 12,438), 5% had AMI–CS, and in patients without AMI (n = 10,309), 2.3% developed CS (non-AMI–CS). Their median age was 63 years and 70.5% were men. Cardiovascular risk factors were more frequent among the AMI–CS group, whereas a history of heart failure was greater in non-AMI–CS patients (70.1%). In AMI-CS patients, the median delay time was 17.2 hours from the onset of AMI symptoms to hospital admission. Overall, the median left ventricular ejection fraction (LVEF) was 30%. Patients with CS at admission showed end-organ dysfunction, evidenced by lactic acidosis, renal impairment, and elevated liver transaminases. Of the 620 AMI–CS patients, the main cause was left ventricular dysfunction in 71.3%, mechanical complications in 15.2% and right ventricular infarction in 13.5%. Among the 213 non-AMI–CS patients, valvular heart disease (49.3%) and cardiomyopathies (42.3%) were the most frequent etiologies. In-hospital all-cause mortality rates were 69.7% and 72.3% in the AMI–CS and non-AMI–CS groups, respectively. Among AMI–CS patients, renal dysfunction, diabetes, older age, depressed LVEF, absence of revascularization and the use of mechanical ventilation were independent predictors of in-hospital mortality. However, in the non-AMI–CS group, only low LVEF and high lactate levels proved significant. This study demonstrates differences in the epidemiology of CS compared to high-income countries; the high mortality reflects critically ill patients and the lack of contemporary effective therapies in the population studied.

23 September 2023 in Echocardiography
Verified
Journal Article
Closed access
JUJose Daniel Utrilla‐Alvarez
Jose Daniel Utrilla‐Alvarez
RGRodrigo Gopar‐Nieto
Rodrigo Gopar‐Nieto
EGEdgar García‐Cruz
Edgar García‐Cruz
ELEmmanuel Lazcano‐Díaz
Emmanuel Lazcano‐Díaz
GJGian Manuel Jiménez‐Rodrìguez
Gian Manuel Jiménez‐Rodrìguez
DMDaniel Manzur‐Sandoval
Daniel Manzur‐Sandoval

29 June 2023 in Echo Research & Practice
Verified
Journal Article
Open access
PDF file
APAldo Pérez-Manjarrez
Aldo Pérez-Manjarrez
EGEdgar García-Cruz
Edgar García-Cruz
RGRodrigo Gopar-Nieto
Rodrigo Gopar-Nieto
GJGian Manuel Jiménez-Rodríguez
Gian Manuel Jiménez-Rodríguez
ELEmmanuel Lazcano-Díaz
Emmanuel Lazcano-Díaz
DMDaniel Manzur-Sandoval
Daniel Manzur-Sandoval
Background: Haemodynamic monitoring of patients after cardiac surgery using echocardiographic evaluation of fluid responsiveness is both challenging and increasingly popular. We evaluated fluid responsiveness in the first hours after surgery by determining the variability of the velocity–time integral of the left ventricular outflow tract (VTI-LVOT). Methods: We conducted a cross-sectional study of 50 consecutive adult patients who underwent cardiac surgery and in whom it was possible to obtain VTI-LVOT measurements. We then determined the variability and correlations with our pulse pressure variation (PPV) measurements to predict fluid responsiveness. Results: A strong positive correlation was seen between the VTI-LVOT variability index absolute values and PPV for predicting fluid responsiveness in the first hours after cardiac surgery. We also found that the VTI-LVOT variability index has high specificity and a high positive likelihood ratio compared with the gold standard using a cut-off point of ≥ 12%. Conclusions: The VTI-LVOT variability index is a valuable tool for determining fluid responsiveness during the first 6 postoperative hours in patients undergoing cardiac surgery.